BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31487418)

  • 1. NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma.
    Gao Y; Wang Z; Zhu Y; Zhu Q; Yang Y; Jin Y; Zhang F; Jiang L; Ye Y; Li H; Zhang Y; Liang H; Xiang S; Miao H; Liu Y; Hao Y
    Cancer Sci; 2019 Nov; 110(11):3510-3519. PubMed ID: 31487418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy-related-1 in vitro and in vivo.
    Zhai CT; Tian YC; Tang ZX; Shao LJ
    Kaohsiung J Med Sci; 2021 Nov; 37(11):991-999. PubMed ID: 34370374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HASPIN is involved in the progression of gallbladder carcinoma.
    Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
    Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
    Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
    Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer.
    Chen SY; Chen KL; Ding LY; Yu CH; Wu HY; Chou YY; Chang CJ; Chang CH; Wu YN; Wu SR; Hou YC; Lee CT; Chen PC; Shan YS; Huang PH
    Oncogene; 2022 May; 41(22):3162-3176. PubMed ID: 35501460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo.
    Jung J; Son YS; Park H; Jeon SK; Lee JW; Choi SY; Kim JM; Kwon YG; Hong HJ; Min JK
    Oncol Rep; 2011 Apr; 25(4):945-52. PubMed ID: 21318226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
    Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
    J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
    Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
    Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-20a triggers metastasis of gallbladder carcinoma.
    Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
    J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
    Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
    Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):603-7. PubMed ID: 15567755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.
    Zou S; Huang Y; Yang Z; Zhang J; Meng M; Zhang Y; Feng J; Sun R; Li W; Wang W; López JG; Fang L
    Clin Transl Med; 2024 Mar; 14(3):e1621. PubMed ID: 38468490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
    Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
    Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m
    Chen L; Ding J; Wang B; Chen X; Ying X; Yu Z; Dong P
    Exp Cell Res; 2021 Jul; 404(2):112664. PubMed ID: 34048786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma.
    Wang W; Chen LC; Qian JY; Zhang Q
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9829-9839. PubMed ID: 31799650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Wang N; Chen RX; Deng MH; Wei WS; Zhou ZH; Ning K; Li YH; Li XD; Ye YL; Wen JH; Dong B; Zhang XP; Liu ZW; Zhou FJ
    Cell Death Dis; 2023 Feb; 14(2):139. PubMed ID: 36806253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.